A potential miracle drug developed by Biogen failed to meet the endpoints of a Phase II clinical trial.
Biogen Inc.’s keenly watched experimental drug for treating multiple sclerosis failed to meet the main goal of improving some symptoms in a mid-stage study.
A once-per-month injection for MS developed by Biogen and AbbVie received FDA approval.
FORUM Pharmaceuticals is laying off 77 people starting immediately, with another 12 job losses possible. There are unconfirmed rumors that the company may shut down.
Indianapolis-based Eli Lilly and Company is on a roll, announcing that between 2014 and 2023, it may launch 20 new products.
After the announcement by Biogen that it was spinning off its hemophilia business, analysts and investors are pondering, somewhat quizzically, just what it means.
Biogen Inc. plans to spin off its hemophilia drug business as a publicly traded company, leaving the drugmaker to focus on developing drugs for neurodegenerative diseases.
(Reuters Health) – People with early Alzheimer’s disease who consumed light to moderate amounts of alcohol every day were less likely to die during a recent one-year study, researchers found. “These results are somewhat surprising because Alzheimer´s disease is a neurodegenerative disease and we know that alcohol can have harmful effects on the brain,” said […]
Anavex Life Sciences Corp. (NASDAQ:AVXL) may have just emerged as a significant player in the Alzheimer’s drug market. The clinical-stage biotech company specializes in the development of treatments for currently incurable diseases. It has stumbled upon AVANEX 3-71 which is a drug candidate that may have significant potential for reduction of synaptic loss, amyloid, and […]
MILWAUKEE and SALT LAKE CITY, Aug. 21, 2015 /PRNewswire/ — Today, Blackrock NeuroMed LLC and the Children’s Hospital of Wisconsin announced a clinical affiliation that will advance the treatment of childhood epilepsy and provide insight into other neurodegenerative diseases. At the heart of the clinical affiliation is Blackrock NeuroMed’s Cervello System, which allows doctors to examine […]